Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/292060

Repository DOI

https://doi.org/10.17863/CAM.39214

Files

Published version (819.83 KB)

Type

Authors

Eckstein, Olive S

https://orcid.org/0000-0002-1895-8810

Visser, Johannes

Rodriguez-Galindo, Carlos

NACHO-LIBRE Study Group

Keywords

Blood Cells, Child, Databases, Genetic, Histiocytosis, Langerhans-Cell, Humans, Mutation, Proto-Oncogene Proteins B-raf

Journal Title

Blood

Journal ISSN

0006-4971
1528-0020

Volume Title

133

Publisher

American Society of Hematology

Publisher DOI

https://doi.org/10.1182/blood-2018-10-878363

Rights and licensing

All rights reserved

Except where otherwised noted, this item's license is described as All rights reserved

Collections

University of Cambridge Research Outputs (Articles and Conferences)